ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
HRTX
#3019
Heron Therapeutics, Inc.
1.1
9
-0.83%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
-0.83%
月次変化
-14.39%
6か月変化
-11.85%
1年の変化
-39.90%
以前の終値
1.2
0
Open
1.1
9
Bid
Ask
Low
1.1
9
High
1.1
9
ボリューム
58
マーケット
株
ヘルスケア
HRTX
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
152.09 M
152.33 M
152.56 M
153.29 M
183.36 M
188.54 M
—
Valuation ratios
Enterprise value
276.93 M
207.26 M
316.37 M
300.8 M
195.83 M
217.5 M
1.03 B
Price to earnings ratio
-16.58
-17
-36.67
-103.5
-14
-10.83
-165
Price to sales ratio
2.14
1.62
2.4
2.25
1.35
—
—
Price to cash flow ratio
37.31
10.35
16.86
12.12
6.81
7.85
43.64
Price to book ratio
2.03
6.93
2.51
2.57
2.16
16.32
23.56
Enterprise value to EBITDA ratio
-9.99
3.78
33.98
9.42
3.22
—
—
Profitability ratios
Return on assets %
0.02
-0.02
0.01
0.01
0.05
0.01
0.08
Return on equity %
0.12
-0.11
0.09
0.09
0.82
0.21
1.21
Return on invested capital %
—
-60.74
—
—
—
-46.27
—
Gross margin %
71.17
74.92
78.26
73.5
68.82
72.61
293.19
Operating margin %
13.59
-10.23
8.11
4.4
10.71
-15.64
7.58
EBITDA margin %
-14.34
11.68
47.11
36.41
63.52
1.42
148.46
Net margin %
14.78
-8.98
6.77
6.4
31.99
7.28
52.44
Liquidity ratios
Quick ratio
1.74
1.7
1.76
0.53
1.78
1.51
5.58
Current ratio
2.28
2.29
2.4
0.82
2.56
2.48
8.25
Inventory turnover
0.21
0.21
0.15
0.15
0.17
0.14
0.61
Asset turnover
0.15
0.18
0.17
0.16
0.16
0.16
0.64
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.68
0.64
0.64
0.65
0.13
0.13
1.54
Long term debt to total equity ratio
3.74
4.45
5.26
5.5
2.16
2.28
15.2
Per share metrics
Operating cash flow per share
-0.02
0.08
0.05
0.07
-0.01
0.06
0.16
EBIT per share
-0.03
0.03
0.09
0.08
0.14
0
0.31
EBITDA per share
-0.03
0.03
0.09
0.09
0.14
0
0.33
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.46
0.39
0.26
0.26
0.33
0.28
1.13
Net current asset value per share
1.28
1.37
1.08
1.37
1.35
1.43
5.23
Tangible book value per share
0.26
0.22
0.14
0.18
0.04
0.08
0.44
Working capital per share
0.72
0.77
0.63
-0.31
0.82
0.85
1.99
Book value per share
0.26
0.22
0.14
0.18
0.04
0.08
0.44
ニュース
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript
Heron Therapeuti kazancı beklentilere göre daha kötü, kâr ise beklentilere göre yüksek
Heron Therapeuti earnings missed, revenue topped estimates
Heron’un 4Ç 2025 sunumu: akut bakım atılımı ZYNRELEF’te %48 büyüme sağladı
Heron Q4 2025 slides: acute care surge drives 48% ZYNRELEF growth
Heron Therapeutics hisseleri güçlü 4. çeyrek gelir büyümesiyle yükseldi
Heron Therapeutics stock soars after strong Q4 revenue growth
Heron’s APONVIE featured in new postoperative nausea guidelines
Jefferies, Heron Therapeutics’in onkoloji franchise’ının düşüşü nedeniyle hedef fiyatını düşürdü
Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline
Heron Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HRTX) 2025-11-04
Heron Therapeutics 2025 3. Çeyrek: Kazanç Beklentilerini Karşılayamasa da Güçlü Ürün Büyümesi